Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Suvorexant for Primary Insomnia: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials
Taro Kishi, Shinji Matsunaga, Nakao Iwata
PLoS ONE (2015) Vol. 10, Iss. 8, pp. e0136910-e0136910
Open Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

Review of Safety and Efficacy of Sleep Medicines in Older Adults
Jennifer Schroeck, James M. Ford, Erin Conway, et al.
Clinical Therapeutics (2016) Vol. 38, Iss. 11, pp. 2340-2372
Open Access | Times Cited: 308
Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery
Tobias Atkin, Stefano Comai, Gabriella Gobbi
Pharmacological Reviews (2018) Vol. 70, Iss. 2, pp. 197-245
Open Access | Times Cited: 306
Advances in the management of chronic insomnia
Margaret Kay-Stacey, Hrayr Attarian
BMJ (2016), pp. i2123-i2123
Closed Access | Times Cited: 144
Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: A double-blind, randomised clinical trial
Tracey L. Sletten, Michelle Magee, Jade M. Murray, et al.
PLoS Medicine (2018) Vol. 15, Iss. 6, pp. e1002587-e1002587
Open Access | Times Cited: 120
Comparative effectiveness and safety of pharmacological and non-pharmacological interventions for insomnia: an overview of reviews
Patricia Rios, Roberta Cardoso, Deanna E. Morra, et al.
Systematic Reviews (2019) Vol. 8, Iss. 1
Open Access | Times Cited: 112
Lemborexant vs suvorexant for insomnia: A systematic review and network meta-analysis
Taro Kishi, Ikuo Nomura, Yuki Matsuda, et al.
Journal of Psychiatric Research (2020) Vol. 128, pp. 68-74
Closed Access | Times Cited: 79
Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders
Ying Han, Kai Yuan, Yongbo Zheng, et al.
Neuroscience Bulletin (2019) Vol. 36, Iss. 4, pp. 432-448
Open Access | Times Cited: 77
Practitioner Review: Treatment of chronic insomnia in children and adolescents with neurodevelopmental disabilities
Oliviero Bruni, Marco Angriman, Fabrizio Calisti, et al.
Journal of Child Psychology and Psychiatry (2017) Vol. 59, Iss. 5, pp. 489-508
Open Access | Times Cited: 77
Pharmacotherapeutic management of sleep disorders in children with neurodevelopmental disorders
Oliviero Bruni, Marco Angriman, Maria Grazia Melegari, et al.
Expert Opinion on Pharmacotherapy (2019) Vol. 20, Iss. 18, pp. 2257-2271
Closed Access | Times Cited: 62
Sleep Disturbance After TBI
Surendra Barshikar, Kathleen Bell
Current Neurology and Neuroscience Reports (2017) Vol. 17, Iss. 11
Closed Access | Times Cited: 61
Central and peripheral circadian clocks and their role in Alzheimer's disease
Ruchi Chauhan, Ko‐Fan Chen, Brianne A. Kent, et al.
Disease Models & Mechanisms (2017) Vol. 10, Iss. 10, pp. 1187-1199
Open Access | Times Cited: 53
A sleeping giant: Suvorexant for the treatment of alcohol use disorder?
Erin J. Campbell, Nathan J. Marchant, Andrew J. Lawrence
Brain Research (2018) Vol. 1731, pp. 145902-145902
Closed Access | Times Cited: 50
Analysis of sleep medication‐induced parasomnias using the Japanese Adverse Drug Event Report database
Shotaro Kobayashi, Koji Shinozaki, Hiroyuki Nagano, et al.
Journal of Sleep Research (2025)
Open Access
Novel class of medications, orexin receptor antagonists, in the treatment of insomnia – critical appraisal of suvorexant
Sarah L. Anderson, Jessica Norman
Nature and Science of Sleep (2016) Vol. Volume 8, pp. 239-247
Open Access | Times Cited: 44
Orexin receptor antagonists for the treatment of insomnia and potential treatment of other neuropsychiatric indications
W. Joseph Herring, Thomas Roth, Andrew D. Krystal, et al.
Journal of Sleep Research (2018) Vol. 28, Iss. 2
Closed Access | Times Cited: 44
Orexin-1 receptor blockade suppresses compulsive-like alcohol drinking in mice
Kelly Lei, Scott A. Wegner, Ji-Hwan Yu, et al.
Neuropharmacology (2016) Vol. 110, pp. 431-437
Open Access | Times Cited: 42
Efficacy and safety of non-benzodiazepine and non-Z-drug hypnotic medication for insomnia in older people: a systematic literature review
Judith Sys, Simon Van Cleynenbreugel, Mieke Deschodt, et al.
European Journal of Clinical Pharmacology (2019) Vol. 76, Iss. 3, pp. 363-381
Closed Access | Times Cited: 40
Clinical safety and narcolepsy-like symptoms of dual orexin receptor antagonists in patients with insomnia: a systematic review and meta-analysis
Hyun-jin Na, Nakyung Jeon, Christine E. Staatz, et al.
SLEEP (2023) Vol. 47, Iss. 2
Closed Access | Times Cited: 12
Suvorexant for the Treatment of Insomnia in Adolescents
Kentaro Kawabe, Fumie Horiuchi, Marina Ochi, et al.
Journal of Child and Adolescent Psychopharmacology (2017) Vol. 27, Iss. 9, pp. 792-795
Closed Access | Times Cited: 37
Suvorexant for the prevention of delirium
Shu Xu, Yuanyuan Cui, Jinhua Shen, et al.
Medicine (2020) Vol. 99, Iss. 30, pp. e21043-e21043
Open Access | Times Cited: 29
Evidence‐based insomnia treatment strategy using novel orexin antagonists: A review
Taro Kishi, Maika Nishida, Michinori Koebis, et al.
Neuropsychopharmacology Reports (2021) Vol. 41, Iss. 4, pp. 450-458
Open Access | Times Cited: 23
Pain management in people with severe mental illness: an agenda for progress
Juliana Onwumere, Brendon Stubbs, Mary Stirling, et al.
Pain (2022) Vol. 163, Iss. 9, pp. 1653-1660
Open Access | Times Cited: 17
Effect of discontinuation of lemborexant following long‐term treatment of insomnia disorder: Secondary analysis of a randomized clinical trial
Yoshikazu Takaesu, Masahiro Suzuki, Margaret Moline, et al.
Clinical and Translational Science (2022) Vol. 16, Iss. 4, pp. 581-592
Open Access | Times Cited: 15
Hyperarousal during sleep in untreated primary insomnia sufferers: A polysomnographic study
Matthieu Hein, Christelle Senterre, Jean‐Pol Lanquart, et al.
Psychiatry Research (2017) Vol. 253, pp. 71-78
Closed Access | Times Cited: 26
Hypocretin Mediates Sleep and Wake Disturbances in a Mouse Model of Traumatic Brain Injury
Hannah E. Thomasy, Mark R. Opp
Journal of Neurotrauma (2018) Vol. 36, Iss. 5, pp. 802-814
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top